HDAC9 and neoplasm: HDAC inhibitors have demonstrated the potential to be potent anticancer agents and are noted for their ability to induce tumor-suppressor genes as well as genes involved in cellular differentiation and apoptosis frequently found to be repressed in malignant cells.